MBX

NASDAQStock

MBX Biosciences, Inc. Common Stock

$27.45-0.50 (-1.79%)

52-Week Range

$5.79
$43.14

Key Stats

Market Cap

922.1M

P/E Ratio

3.57

Dividend Yield

Beta

1.07

Volume

482.2K

Avg Volume

591.4K

Performance

1M

-26.45%

3M

-1.52%

6M

+157.13%

YTD

-8.51%

1Y

+221.26%

3Y

+18.18%

5Y

+18.18%

Price Chart

ETF Exposure

MBX is held by 63 ETFs

ETFFund NameWeight
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
DFUSDimensional - US Equity Market ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
PreviousPage 2 of 2

About MBX ETF Exposure

MBX Biosciences, Inc. Common Stock (MBX) is held by 63 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 922.1M, MBX is a widely held institutional stock. The stock currently trades at $27.45. Investors can gain exposure to MBX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MBX, sorted by portfolio weight.